Public-registry site landscape for NCT02905565, a AIS study sponsored by CSPC-NBP Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02905565 (registry record) |
| Sponsor | CSPC-NBP Pharmaceutical Co., Ltd. |
| Condition(s) | AIS |
| Phase | PHASE2 |
| Listed sites | 21 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT02905565 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →